Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Friday, April 18, 2025, on account of Good Friday.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

S Chand And Company Ltd Share Price

₹ 211.58 2.35 (1.12%)

Apr 17 2025 03:30 PM Printing & Stationery NSE: SCHAND

S Chand And Company Ltd Share Price Update

As of the latest trading session, S Chand And Company Ltd share price is currently at 211.58, which is up by 2.35 from its previous closing. Today, the stock has fluctuated between 207.48 and 218.83. Over the past year, S Chand And Company Ltd has achieved a return of -9.30 %. In the last month alone, the return has been 21.66 %. Read More...

S Chand And Company Ltd Performance

Day Range

Low207.48 High218.83

211.58

52 Week Range

Low 156.91 High 255.95

211.58

S Chand And Company Ltd Share Price

20698

540497

SCHAND

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

211.00 Prev. Close

209.23 Volume (Shares)

86552.00

Total traded value

183.12 Upper Circuit

251.07 Lower Circuit

167.38

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

S Chand And Company Ltd Fundamentals

(Standalone)

Market Cap (Cr)	743.83
PE Ratio (TTM)	64.62
Book Value / Share	237.57
Beta	0.69

ROE	1.74%
EPS (TTM)	3.52
Dividend Yield	1.41%
Net Profit Qtr (Cr)	-13.77

S Chand And Company Ltd Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	33.14
Operating Expense	53.79
Net Profit	-13.77
Net Profit Margin (%)	-41.55
Earnings Per Share (EPS)	-3.91
EBITDA	-15.10
Effective Tax Rate (%)	28.54

Particulars	SEP 2024 (Values in Cr)
Revenue	26.24
Operating Expense	45.12
Net Profit	-8.58
Net Profit Margin (%)	-32.69
Earnings Per Share (EPS)	-2.44
EBITDA	-7.83
Effective Tax Rate (%)	25.56

Particulars	JUN 2024 (Values in Cr)
Revenue	53.38
Operating Expense	50.29
Net Profit	3.08
Net Profit Margin (%)	5.76
Earnings Per Share (EPS)	0.87
EBITDA	8.92
Effective Tax Rate (%)	35.56

Particulars	MAR 2024 (Values in Cr)
Revenue	161.90
Operating Expense	115.53
Net Profit	30.82
Net Profit Margin (%)	19.03
Earnings Per Share (EPS)	8.75
EBITDA	52.66
Effective Tax Rate (%)	34.10

Particulars	DEC 2023 (Values in Cr)
Revenue	21.25
Operating Expense	47.16
Net Profit	-14.04
Net Profit Margin (%)	-66.07
Earnings Per Share (EPS)	-3.99
EBITDA	-13.89
Effective Tax Rate (%)	29.04

Particulars	MAR 2024 (Values in Cr)
Revenue	250.56
Operating Expense	249.69
Net Profit	14.79
Net Profit Margin (%)	5.90
Earnings Per Share (EPS)	4.20
EBITDA	36.21
Effective Tax Rate (%)	-26.71

Particulars	MAR 2023 (Values in Cr)
Revenue	227.65
Operating Expense	237.05
Net Profit	4.25
Net Profit Margin (%)	1.86
Earnings Per Share (EPS)	1.21
EBITDA	38.67
Effective Tax Rate (%)	58.43

Particulars	MAR 2022 (Values in Cr)
Revenue	169.97
Operating Expense	177.25
Net Profit	8.87
Net Profit Margin (%)	5.21
Earnings Per Share (EPS)	2.53
EBITDA	32.00
Effective Tax Rate (%)	24.38

Particulars	MAR 2021 (Values in Cr)
Revenue	143.04
Operating Expense	160.95
Net Profit	2.22
Net Profit Margin (%)	1.55
Earnings Per Share (EPS)	0.64
EBITDA	27.76
Effective Tax Rate (%)	30.62

Particulars	MAR 2020 (Values in Cr)
Revenue	151.06
Operating Expense	202.09
Net Profit	-39.73
Net Profit Margin (%)	-26.30
Earnings Per Share (EPS)	-11.36
EBITDA	-21.13
Effective Tax Rate (%)	13.00

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	267.20
ROE %	5.22
ROCE %	6.27
Total Debt to Total Equity	0.15
EBITDA Margin	13.90

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	254.75
ROE %	4.09
ROCE %	6.03
Total Debt to Total Equity	0.19
EBITDA Margin	13.82

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	237.26
ROE %	0.97
ROCE %	3.06
Total Debt to Total Equity	0.25
EBITDA Margin	12.54

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	233.96
ROE %	0.56
ROCE %	2.89
Total Debt to Total Equity	0.31
EBITDA Margin	14.12

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	234.00
ROE %	-12.75
ROCE %	-5.62
Total Debt to Total Equity	0.29
EBITDA Margin	-4.26

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	242.32
ROE %	1.74
ROCE %	2.56
Total Debt to Total Equity	0.12
EBITDA Margin	11.79

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	241.48
ROE %	1.02
ROCE %	4.13
Total Debt to Total Equity	0.13
EBITDA Margin	17.07

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	227.24
ROE %	1.12
ROCE %	2.71
Total Debt to Total Equity	0.11
EBITDA Margin	15.07

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	224.65
ROE %	0.33
ROCE %	2.16
Total Debt to Total Equity	0.14
EBITDA Margin	15.95

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	223.80
ROE %	-3.67
ROCE %	-2.15
Total Debt to Total Equity	0.15
EBITDA Margin	-5.54

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	127.25
Total Assets	1273.42
Total Liabilities	1273.42
Total Equity	943.91
Share Outstanding	35156336
Price to Book Ratio	0.96
Return on Assets (%)	4.01
Return on Capital (%)	4.86

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	80.69
Total Assets	1220.10
Total Liabilities	1220.10
Total Equity	903.97
Share Outstanding	35156336
Price to Book Ratio	0.92
Return on Assets (%)	4.72
Return on Capital (%)	5.59

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	67.51
Total Assets	1193.29
Total Liabilities	1193.29
Total Equity	847.30
Share Outstanding	35043336
Price to Book Ratio	0.43
Return on Assets (%)	0.93
Return on Capital (%)	1.11

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	48.48
Total Assets	1235.88
Total Liabilities	1235.88
Total Equity	837.14
Share Outstanding	34975287
Price to Book Ratio	0.47
Return on Assets (%)	-0.52
Return on Capital (%)	-0.62

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	10.53
Total Assets	1290.80
Total Liabilities	1290.80
Total Equity	821.30
Share Outstanding	34975287
Price to Book Ratio	0.17
Return on Assets (%)	-8.63
Return on Capital (%)	-11.22

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	51.20
Total Assets	1035.58
Total Liabilities	1035.58
Total Equity	853.41
Share Outstanding	35156336
Price to Book Ratio	0.96
Return on Assets (%)	1.42
Return on Capital (%)	1.61

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	38.41
Total Assets	1069.24
Total Liabilities	1069.24
Total Equity	848.95
Share Outstanding	35156336
Price to Book Ratio	0.92
Return on Assets (%)	0.39
Return on Capital (%)	0.43

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	28.55
Total Assets	943.90
Total Liabilities	943.90
Total Equity	796.35
Share Outstanding	35043336
Price to Book Ratio	0.43
Return on Assets (%)	0.93
Return on Capital (%)	1.02

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	20.26
Total Assets	962.26
Total Liabilities	962.26
Total Equity	785.75
Share Outstanding	34975287
Price to Book Ratio	0.47
Return on Assets (%)	0.23
Return on Capital (%)	0.25

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	1.37
Total Assets	986.19
Total Liabilities	986.19
Total Equity	782.74
Share Outstanding	34975287
Price to Book Ratio	0.17
Return on Assets (%)	-4.02
Return on Capital (%)	-4.48

Particulars	MAR 2024 (Values in Cr)
Net Income	58.24
Cash from Operations	144.27
Cash from Investing	-24.07
Cash from Financing	-53.02
Net change in Cash	43.99
Free Cash Flow	161.83

Particulars	MAR 2023 (Values in Cr)
Net Income	77.66
Cash from Operations	99.37
Cash from Investing	-4.41
Cash from Financing	-60.69
Net change in Cash	15.96
Free Cash Flow	115.54

Particulars	MAR 2022 (Values in Cr)
Net Income	4.56
Cash from Operations	118.30
Cash from Investing	-2.76
Cash from Financing	-84.81
Net change in Cash	18.97
Free Cash Flow	134.24

Particulars	MAR 2021 (Values in Cr)
Net Income	-0.02
Cash from Operations	97.77
Cash from Investing	-17.61
Cash from Financing	-57.93
Net change in Cash	32.10
Free Cash Flow	109.51

Particulars	MAR 2020 (Values in Cr)
Net Income	-98.68
Cash from Operations	61.37
Cash from Investing	-17.71
Cash from Financing	-81.45
Net change in Cash	-50.73
Free Cash Flow	89.43

Particulars	MAR 2024 (Values in Cr)
Net Income	11.67
Cash from Operations	47.49
Cash from Investing	66.60
Cash from Financing	-94.57
Net change in Cash	15.84
Free Cash Flow	56.12

Particulars	MAR 2023 (Values in Cr)
Net Income	10.20
Cash from Operations	26.55
Cash from Investing	7.39
Cash from Financing	-23.19
Net change in Cash	8.61
Free Cash Flow	37.36

Particulars	MAR 2022 (Values in Cr)
Net Income	11.72
Cash from Operations	42.49
Cash from Investing	1.89
Cash from Financing	-37.26
Net change in Cash	8.16
Free Cash Flow	45.84

Particulars	MAR 2021 (Values in Cr)
Net Income	3.20
Cash from Operations	43.40
Cash from Investing	-5.48
Cash from Financing	-30.77
Net change in Cash	16.06
Free Cash Flow	45.08

Particulars	MAR 2020 (Values in Cr)
Net Income	-45.66
Cash from Operations	18.33
Cash from Investing	3.77
Cash from Financing	-42.63
Net change in Cash	-22.71
Free Cash Flow	27.29

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
NAVNEET EDUCATION LTD	141.65	18.37	1.77	3204.31	127.20 / 179.05
KAISER CORPORATION LIMITED	6.64	0.00	4.77	34.94	4.03 / 12.70
LINC LIMITED	106.25	16.87	2.95	632.07	97.00 / 207.15
REPRO INDIA LIMITED	478.65	0.00	1.78	685.59	380.30 / 884.05

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
INFOMEDIA PRESS LIMITED	6.15	0.00	-0.54	30.87	4.80 / 9.58
KOKUYO CAMLIN LIMITED	110.55	93.69	3.73	1108.86	91.00 / 230.40
NAVNEET EDUCATION LTD	141.65	13.73	1.65	3204.31	127.20 / 179.05
SHAKTI PRESS LTD.	26.56	0.00	0.49	9.35	23.00 / 39.97

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 203.40
26 Days 185.30
10 Days 195.40
50 Days 185.00
12 Days 193.10
100 Days 192.60
20 Days 187.30
200 Days 204.80

207.41
PIVOT

First Resistance	211.82
Second Resistance	214.40
Third Resistance	218.81

First Support	204.83
Second Support	200.42
Third Support	197.84

RSI	75.40
MACD	7.86
Commodity Channel Index (CCI)	180.17

ADX	29.98
Williams % R	-13.47

S Chand And Company Ltd Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

44.7 Promoter Holdings

47.06 FII

4.41 DII

3.82 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Himanshu Gupta	Shareholding of Promoter and Promoter Group	5994038.0	17.02
Neerja Jhunjhnuwala	Shareholding of Promoter and Promoter Group	4008345.0	11.38
Dinesh Kumar Jhunjhnuwala	Shareholding of Promoter and Promoter Group	3846854.0	10.92
Srinivasan Varadarajan	Public Shareholding	1552250.0	4.41
Savita Gupta	Shareholding of Promoter and Promoter Group	1218617.0	3.46
The Miri Strategic Emerging Markets Fund Lp	Public Shareholding	929078.0	2.64
Ankita Gupta	Shareholding of Promoter and Promoter Group	914078.0	2.6
Trustline Deep Alpha Aif	Public Shareholding	865450.0	2.46
Blue Daimond Properties Pvt Ltd	Public Shareholding	701129.0	1.99
Gaurav Kumar Jhunjhnuwala	Shareholding of Promoter and Promoter Group	592000.0	1.68
Volrado Venture Partners Fund Ii	Public Shareholding	481500.0	1.37
Zen Securities Ltd	Public Shareholding	430000.0	1.22

S Chand And Company Ltd

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2023-09-18	3.0	Final	2023-09-19	Equity shares	2018-09-17	1.5	Final	2018-09-19	Equity shares	2017-09-15	1.25	Final	2017-09-18	Equity shares

Learn More About Stocks

Zydus Lifesciences Invests in Feldan to Boost Drug Delivery Innovation

Zydus Lifesciences’ VC arm Zynext Ventures invests in Canada’s Feldan Therapeutics to advance innovation in intracellular drug delivery technologies.

17 Apr, 2025 | 3 Min. read

DLF To Sell Kolkata IT SEZ To Srijan Group For Rs.693 Crore

DLF Ltd to sell its 25.9-acre Kolkata IT SEZ, including DLF Tech Park, to Srijan Group for Rs.693 crore through a slump sale.

17 Apr, 2025 | 3 Min. read

UltraTech Cement Acquires 26% Stake in Solar SPV for Rs.25.5 Crore

UltraTech Cement to invest Rs.25.5 crore for a 26% stake in AMPIN C&I Power Eight to secure green energy for operations and reduce power costs.

17 Apr, 2025 | 3 Min. read

BHEL Signs Tech Deal With BARC to Cut Green Hydrogen Costs

BHEL partners with BARC to adopt indigenous diaphragm technology for electrolysers, aiming to cut green hydrogen costs and reduce import dependency.

17 Apr, 2025 | 2 Min. read

CCI Approves Aster DM–Quality Care Merger; New Entity Named Aster DM Quality Care

CCI clears merger of Aster DM Healthcare and Quality Care India Ltd, forming Aster DM Quality Care Ltd. Combined entity to operate 38 hospitals with 10,150 beds.

16 Apr, 2025 | 3 Min. read

ICICI Lombard Q4 Profit Falls 1.9%, Declares ₹7 Final Dividend

ICICI Lombard Q4 net profit declines by 1.9% YoY to ₹509.6 crore, while FY25 PAT jumps 30.7%. Board declares ₹7 final dividend, total ₹12.5 for FY25.

16 Apr, 2025 | 3 Min. read

IndusInd Bank Finds ₹1,979 Crore Net Worth Hit in Derivatives Audit

An external audit reveals ₹1,979 crore impact on IndusInd Bank’s net worth due to derivative discrepancies. Bank to reflect changes in FY25 financial reports.

16 Apr, 2025 | 2 Min. read

Oil India Wins 9 Blocks in OALP Round-IX, Acreage Jumps 85%

Oil India secures 9 exploration blocks in OALP Round-IX, expanding its acreage by 85% to 1.10 lakh sq km. ONGC, Cairn, and BP also win key bids.

16 Apr, 2025 | 3 Min. read

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

About S Chand And Company Ltd

Companies Owned by S Chand And Company Ltd

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Frequently Asked Questions

What is the Share Price of S Chand & Company Ltd?

Answer Field: The share price of S Chand & Company Ltd for NSE is ₹ 211.58 and for BSE is ₹ 210.65.

What is the Market Cap of S Chand & Company Ltd?

Answer Field: The market cap of S Chand & Company Ltd for NSE is ₹ 7,43.83 Cr. and for BSE is ₹ 7,40.56 Cr. as of now.

What is the 52 Week High and Low of S Chand & Company Ltd?

Answer Field: The 52 Week High and Low of S Chand & Company Ltd for NSE is ₹ 255.95 and ₹ 156.91 and for BSE is ₹ 269.90 and ₹ 157.60.

How to Buy S Chand & Company Ltd share?

Answer Field: You can trade in S Chand & Company Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for S Chand & Company Ltd?

Answer Field: The 1 year returns on the stock has been -9.30%.

What is the Current Share Price of S Chand & Company Ltd?

Answer Field: S Chand & Company Ltd share price is for NSE ₹ 211.58 & for BSE ₹ 210.65 as on Apr 17 2025 03:30 PM.

What is the Market Cap of S Chand & Company Ltd Share?

Answer Field: The market cap of S Chand & Company Ltd for NSE ₹ 7,43.83 & for BSE ₹ 7,40.56 as on Apr 17 2025 03:30 PM.

What is the P/E Ratio of S Chand & Company Ltd Share?

Answer Field: As on Apr 17 2025 03:30 PM the price-to-earnings (PE) ratio for S Chand & Company Ltd share is 64.62.

What is the PB ratio of S Chand & Company Ltd Share?

Answer Field: As on Apr 17 2025 03:30 PM, the price-to-book (PB) ratio for S Chand & Company Ltd share is 237.57.

How to Buy S Chand & Company Ltd Share?

Answer Field: You can trade in S Chand & Company Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy S Chand & Company Ltd Share on Bajaj Broking App?

Answer Field

To buy S Chand & Company Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “S Chand & Company Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9.5 lakh+ Users

4+ App Rating

4 Languages

₹4400+ Cr MTF Book

Open Demat Account

🚨 Trading Holiday 🚨

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

S Chand And Company Ltd Share Price

S Chand And Company Ltd Share Price Update

S Chand And Company Ltd Performance

Day Range

52 Week Range

S Chand And Company Ltd Share Price

Open Price

211.00

Prev. Close

209.23

Volume (Shares)

86552.00

Total traded value

183.12

Upper Circuit

251.07

Lower Circuit

167.38

S Chand And Company Ltd Fundamentals

S Chand And Company Ltd Financials

Revenue

Net income

Technicals

Over 1 Month

21.66

Over 3 Months

3.61

Over 6 Months

-1.20

Over 1 Year

-9.30

Over 3 Years

21.88

Over 5 Years

39.92

S Chand And Company Ltd Future

Future: Price

Discount/Premium

Active Calls

Active Puts

S Chand And Company Ltd Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

44.7

Promoter Holdings

47.06

FII

4.41

DII

3.82

Promoter Shares(Pledge Percentage)

0.0

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

S Chand And Company Ltd

Learn More About Stocks

Zydus Lifesciences Invests in Feldan to Boost Drug Delivery Innovation

DLF To Sell Kolkata IT SEZ To Srijan Group For Rs.693 Crore

UltraTech Cement Acquires 26% Stake in Solar SPV for Rs.25.5 Crore

BHEL Signs Tech Deal With BARC to Cut Green Hydrogen Costs

About S Chand And Company Ltd

Companies Owned by S Chand And Company Ltd

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Frequently Asked Questions

What is the Share Price of S Chand & Company Ltd?

What is the Market Cap of S Chand & Company Ltd?

What is the 52 Week High and Low of S Chand & Company Ltd?

How to Buy S Chand & Company Ltd share?